Post-approval studies (Phase 4)Ended earlyNCT01825577
What this trial is testing
Exploring the Use of Transdermal Methylphenidate to Reduce Fall Risk in Patients With Dementia.
Who this might be right for
DementiaAccidental FallsApathy
St. Louis University 14